Evidence map›Paper›PMID 42800701›Full record

ReviewMolecular metabolism2026

Genetics of type 2 diabetes: Beyond single nucleotide variant studies.

Celeste Moya-Valera, Mariana de Jesus Gallardo-Espinoza, Alex Fernando Arita, Francisco Lara-Hernandez, Maria Elena Quiroz-Rodriguez, Rosario Abellan, Ana-Barbara Garcia-Garcia, Felipe Javier Chaves

Abstract readReview
In one paragraph

Review in Molecular metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Celeste Moya-ValeraGenetics and Diabetes Unit, INCLIVA Biomedical Research Institute, Valencia, 46010, Spain.
Mariana de Jesus Gallardo-EspinozaGenetics and Diabetes Unit, INCLIVA Biomedical Research Institute, Valencia, 46010, Spain.
Alex Fernando AritaGenetics and Diabetes Unit, INCLIVA Biomedical Research Institute, Valencia, 46010, Spain.
Francisco Lara-HernandezGenetics and Diabetes Unit, INCLIVA Biomedical Research Institute, Valencia, 46010, Spain.
Maria Elena Quiroz-RodriguezGenetics and Diabetes Unit, INCLIVA Biomedical Research Institute, Valencia, 46010, Spain.
Rosario AbellanBiochemistry and Molecular Pathology Department, Hospital Clínico Universitario de Valencia, INCLIVA Biomedical Research Institute, Valencia, 46010, Spain.
Ana-Barbara Garcia-GarciaGenetics and Diabetes Unit, INCLIVA Biomedical Research Institute, Valencia, 46010, Spain; CIBERDEM, ISCIII, Madrid, 28029, Spain. Electronic address: a.barbara.garcia@ext.uv.es.
Felipe Javier ChavesGenetics and Diabetes Unit, INCLIVA Biomedical Research Institute, Valencia, 46010, Spain; CIBERDEM, ISCIII, Madrid, 28029, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 Diabetes (T2D) is a complex disease that has increased in prevalence in the last years affecting over 530 million people around the world. T2D increases mortality and morbidity by different mechanisms. As a complex disease, it is caused by many genetic changes and, consequently, T2D genetics has been analyzed from different points of view and using different strategies. Most studies have focused on inherited Single Nucleotide Variants (SNVs) present in genomic DNA, while other types of genetic variants have received less attention. The aim of the present review is to examine the limitations of the studies conducted to date, and the importance of non-SNVs and non-germinal variants in the genetics of this disease. In this way, structural variants, mobile elements and tandem repeats have a crucial role in T2D. In addition, variations in mitochondrial DNA and somatic variations have been shown to play an important role in metabolic alterations that may lead to the development of T2D.

Indexed as

Diabetes Mellitus, Type 2DNA, MitochondrialGenetic Predisposition to DiseaseGenetic VariationHumansMutationPolymorphism, Single NucleotideDNA, MitochondrialCNVsGeneticsGerminal variationsMitochondrial DNAMutationsSNVsSomatic variationsSTRType 2 diabetesVNTR

Identifiers

PMID42800701
PMCPMC13676476

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.